We help your technology transfer office with our specialist life science knowledge; identifying, protecting and advancing your funded research to move discoveries near the clinic.
We have extensive experience commercialising academic research having helped launch 12 drugs including Avastin®, Campath® and Herceptin®, and form 18 start-ups including the UK’s largest and most successful biotech companies, Celltech and CAT. We have negotiated more than 400 commercial licences, and generated over £600 million in royalty revenues for our academic and charity partners.